Georgina Freeman has a background in bioethics, with a focus on research ethics. She received her BSc in Biological Sciences from the University of Calgary, and a MSc in Experimental Medicine specializing in Biomedical Ethics from McGill University. Her thesis focused on the clinical development of cancer therapeutics; specifically, on the ethical justification of risks associated with patient enrolment in trials involving invasive research procedures. After completing her thesis, Gina was a member of the STREAM (Studies of Translation, Ethics and Medicine) research team at McGill, where she investigated the co-development of cancer diagnostics and their associated therapies.

Currently, Georgina is helping to develop W21C’s Home Health Portfolio with Greg Hallihan, David Borkenhagen and Jaime Kaufman.

Georgina’s research interests include: health technology,  patient experience, and quality of evidence.